Dyne Therapeutics Inc (DYN) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Dyne Therapeutics Inc   (NASDAQ: DYN)


Dyne Therapeutics Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Dyne Therapeutics Inc's ROI in the third quarter of 2026?
Dyne Therapeutics Inc recorded a cumulative net loss of $-605 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -57.27%.

Within the Healthcare sector 496 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3162 to 3736.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 49.26 % 41.43 % 28.06 % 24.25 % 32.56 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,144 916 1,029 1,136 807
Return On Investment (TTM) -57.27 % -53.43 % -49.37 % -53.79 % -59.88 %
DYN's Overall Ranking # 3736 # 3162 # 2663 # 2488 #
Seq. Investment Change TTM 8.67 % 6.24 % 10.29 % 17.22 % 2.97 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -605 -519 -452 -446 -424

DYN Company Profile >> Back to DYN Roi Comparisons >> See Annual DYN Return On Investment



Return On Investment DYN's Ranking
Within: No.
Industry # 212
Sector # 497
Overall # 3736

Return On Investment Statistics
High Average Low
107.78 %
-16.81 %
-119.8 %
(Mar 31 2021)   (Dec 31 2023)







Financial Statements
Dyne Therapeutics Inc's III. Quarter Investments $ 1,144 Millions DYN's Balance sheet
Dyne Therapeutics Inc's III. Quarter Income $ -194 Millions Quarterly DYN's Income Statement
DYN's Income by Division See DYN's Income by Division


DYN Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,136 649 114 278 397
Y / Y Investment Growth 75.1 % 469.34 % -59.03 % -29.9 % 15.94 %
Net Income in Millions -446 -317 -236 -168 -149
Y / Y Net Income Growth - - - - -
Annual Return On Investment -39.27 % -48.91 % -206.99 % -60.42 % -37.61 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DYN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DYN's Competitors
Subscribers only: Roi for Dyne Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for DYN's Customers

Other Ratios
DYN's Roa DYN's Inventory Turnover Ratio DYN's Growth Rates DYN's Dividend Statistics
DYN's Profitability Ratios DYN's Asset Turnover Ratio DYN's Dividend Growth
DYN's Roe DYN's Valuation Ratios DYN's Financial Strength Ratios DYN's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI

Date modified: 2026-11-06T05:39:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.